Skip to content

Clinical trials

Observational Drug-Related Side Effects and Adverse Reactions trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Drug-Related Side Effects and Adverse Reactions Phase: Observational Country / region: United States Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20061
20071
20081
20132
20144
20161
20181
20193
20205
20217
20223
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Unknown status5
Recruiting3
Active, not recruiting2
Not yet recruiting2
Withdrawn2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cipherome, Inc.4
Tabula Rasa HealthCare4
Texas A&M University3
Abramson Cancer Center at Penn Medicine2
Children's Hospital of Philadelphia2
Arkansas Children's Hospital Research Institute1
Duke University1
Genelex Corporation1
General Genetics Corporation1
Intermountain Health Care, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Drug-Related Side Effects and Adverse Reactions35
COVID-194
Cardiotoxicity2
Cardiovascular Diseases2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Acute Kidney Injury1
Amyloidosis1
Atrial Fibrillation1
Breast Neoplasms1
Coronary Artery Disease1

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.